These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3195293)

  • 41. [Treatment with sidnonimine derivatives of chronic ischemic heart disease patients].
    Kuz'ko NV
    Vrach Delo; 1984 Jul; (7):79-81. PubMed ID: 6548063
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Results of studies on the use of psychotropic drugs in the treatment of encephalopathies following early childhood brain damage].
    Cwynar S; Rydzyński Z; Weychert A; Simińska S; Madej A; Grzelak L
    Psychiatr Neurol Med Psychol Beih; 1968; 8-9():152-7. PubMed ID: 5006373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of biogenic amines in the pathogenesis of intellectual disorders in children with minimal psychoorganic syndromes].
    Lupandin VM; Lando LI; Gromova EA; Kamenskaia VM; Zykov MB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1538-44. PubMed ID: 716733
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The diagnosis and treatment of the attention deficit syndrome in children].
    Zavadenko NN; Uspenskaia TIu; Suvorinova NIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(1):57-61. PubMed ID: 9163252
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experience with molsidomin].
    Schlimmer P
    ZFA (Stuttgart); 1980 Mar; 56(9):610-1. PubMed ID: 7376699
    [No Abstract]   [Full Text] [Related]  

  • 47. Use of psychotropic medications in young, preschool children: primum non nocere.
    Barbaresi WJ
    Arch Pediatr Adolesc Med; 2003 Feb; 157(2):121-3. PubMed ID: 12580679
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological treatment of conduct disorder.
    Rifkin A
    New Dir Ment Health Serv; 1992; (54):59-63. PubMed ID: 1625659
    [No Abstract]   [Full Text] [Related]  

  • 49. [A spectral analysis of the effect of sidnocarb on the bioelectrical activity of the rat brain].
    Krapivin SV; Sergeeva SA; Khafiz'ianova RKh
    Biull Eksp Biol Med; 1992 Jul; 114(8):161-3. PubMed ID: 1467480
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fragile X syndrome and attention-deficit/hyperactivity disorder symptoms.
    Deshpande PS; Coffey DB
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):639-42. PubMed ID: 22196318
    [No Abstract]   [Full Text] [Related]  

  • 51. [Differentiated psychopharmacotherapy of anergic conditions and the search for predictors of its effectiveness].
    Podgrushnyĭ VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(4):83-6. PubMed ID: 1650106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative characteristics of the antihypoxic efficacy of pharmacologic preparations and barochamber training in man].
    Kovalenko EA; Katkov AIu; Popkov VL; Bobrovnitskiĭ MP; Chabdarova RN
    Fiziol Cheloveka; 1985; 11(5):808-13. PubMed ID: 4076660
    [No Abstract]   [Full Text] [Related]  

  • 53. [Coronary insufficiency. Biological and clinical update. The value of sydnonimines. International symposium. Lyons, 2-3 October 1987. Proceedings].
    Presse Med; 1988 May; 17(20):979-1048. PubMed ID: 2969102
    [No Abstract]   [Full Text] [Related]  

  • 54. The schizophrenic syndrome and attention deficit disorder. Thesis, antithesis, and synthesis?
    Bellak L
    Am Psychol; 1994 Jan; 49(1):25-9. PubMed ID: 8122814
    [No Abstract]   [Full Text] [Related]  

  • 55. Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder.
    Faltinsen EG; Storebø OJ; Gluud C
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):145-146. PubMed ID: 29744668
    [No Abstract]   [Full Text] [Related]  

  • 56. Psychotropic effects of sidnocarb and ladasten in inbred mice with different reaction to emotional stress.
    Levina MN
    Bull Exp Biol Med; 2005 Mar; 139(3):337-9. PubMed ID: 16027847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparability of the WISC and the WISC-R.
    Paal N; Hesterly SO; Wepfer JW
    J Learn Disabil; 1979 May; 12(5):348-51. PubMed ID: 521683
    [No Abstract]   [Full Text] [Related]  

  • 58. Mirror, mirror on the wall: are we prescribing the right psychotropic medications to the right children using the right treatment plan?
    Jellinek MS
    Arch Pediatr Adolesc Med; 2003 Jan; 157(1):14-6. PubMed ID: 12517189
    [No Abstract]   [Full Text] [Related]  

  • 59. Methodology of the evaluation of psychotropic drugs.
    Psychopharmacol Ser; 1990; 8():1-174. PubMed ID: 2377596
    [No Abstract]   [Full Text] [Related]  

  • 60. [New preparations: Sidnocarb, a central nervous system stimulator (3-(beta-phenylisopropyl)-N-phenylcarbamoylsidnonimin].
    Farmatsiia; 1974; 23(5):91-3. PubMed ID: 4464160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.